loading
Schlusskurs vom Vortag:
$55.77
Offen:
$55.88
24-Stunden-Volumen:
11.19M
Relative Volume:
1.06
Marktkapitalisierung:
$110.17B
Einnahmen:
$46.51B
Nettoeinkommen (Verlust:
$-6.54B
KGV:
13.79
EPS:
3.94
Netto-Cashflow:
$12.95B
1W Leistung:
+4.62%
1M Leistung:
+2.68%
6M Leistung:
+22.87%
1J Leistung:
+5.93%
1-Tages-Spanne:
Value
$54.20
$55.90
1-Wochen-Bereich:
Value
$51.81
$56.20
52-Wochen-Spanne:
Value
$39.35
$56.20

Bristol Myers Squibb Co Stock (BMY) Company Profile

Name
Firmenname
Bristol Myers Squibb Co
Name
Telefon
(609) 252-4621
Name
Adresse
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY
Name
Mitarbeiter
34,100
Name
Twitter
@BMSNEWS
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
BMY's Discussions on Twitter

Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-29 Herabstufung Barclays Overweight → Equal Weight
2024-03-11 Herabstufung Societe Generale Buy → Hold
2024-02-06 Herabstufung Redburn Atlantic Buy → Neutral
2024-01-03 Herabstufung BofA Securities Buy → Neutral
2023-11-15 Herabstufung Cantor Fitzgerald Overweight → Neutral
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-02 Herabstufung Daiwa Securities Outperform → Neutral
2023-10-27 Herabstufung BMO Capital Markets Outperform → Market Perform
2023-10-27 Hochstufung HSBC Securities Reduce → Hold
2023-10-27 Herabstufung William Blair Outperform → Mkt Perform
2023-10-20 Fortgesetzt UBS Neutral
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-07-10 Eingeleitet SVB Securities Market Perform
2023-06-28 Eingeleitet Daiwa Securities Outperform
2023-03-06 Eingeleitet Jefferies Hold
2023-01-17 Eingeleitet Cantor Fitzgerald Overweight
2022-11-18 Eingeleitet Credit Suisse Neutral
2022-10-10 Herabstufung Guggenheim Buy → Neutral
2022-09-14 Herabstufung Berenberg Buy → Hold
2022-06-03 Herabstufung Raymond James Outperform → Mkt Perform
2022-04-06 Fortgesetzt Morgan Stanley Underweight
2021-12-17 Eingeleitet Goldman Buy
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-11-19 Eingeleitet BMO Capital Markets Outperform
2021-11-01 Herabstufung Argus Buy → Hold
2021-07-27 Fortgesetzt Truist Buy
2021-04-30 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-04-13 Hochstufung Truist Hold → Buy
2020-11-16 Hochstufung Societe Generale Hold → Buy
2020-11-10 Fortgesetzt Bernstein Mkt Perform
2020-11-06 Herabstufung Gabelli & Co Buy → Hold
2020-10-19 Hochstufung Guggenheim Neutral → Buy
2020-09-29 Eingeleitet Berenberg Buy
2020-07-28 Eingeleitet Raymond James Outperform
2020-04-02 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-03-23 Herabstufung Societe Generale Buy → Hold
2020-02-27 Eingeleitet Barclays Equal Weight
2020-01-06 Fortgesetzt Citigroup Buy
2019-12-13 Hochstufung Argus Hold → Buy
2019-11-22 Fortgesetzt Morgan Stanley Equal-Weight
2019-10-17 Fortgesetzt BofA/Merrill Buy
2019-08-14 Hochstufung Atlantic Equities Neutral → Overweight
2019-05-28 Eingeleitet Goldman Buy
2019-05-20 Herabstufung Argus Buy → Hold
2019-05-03 Hochstufung Barclays Equal Weight → Overweight
2019-05-03 Fortgesetzt JP Morgan Overweight
2019-01-15 Hochstufung Societe Generale Sell → Buy
2018-10-22 Herabstufung Citigroup Buy → Neutral
Alle ansehen

Bristol Myers Squibb Co Aktie (BMY) Neueste Nachrichten

pulisher
Nov 01, 2024

Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious - Benzinga

Nov 01, 2024
pulisher
Nov 01, 2024

BMS Delivers Q3 Beat, Raises 2024 Guidance Amid Strong Demand for Legacy and Newer Drugs - BioSpace

Nov 01, 2024
pulisher
Nov 01, 2024

Bristol-Myers Squibb Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings Call Highlights: Strong Growth and Strategic ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY) - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

A promising schizophrenia drug showed mixed results. What does that mean for patients?WGN Radio - WGN Radio - Chicago

Oct 31, 2024
pulisher
Oct 31, 2024

December 13th Options Now Available For Bristol Myers Squibb (BMY) - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript - The Motley Fool

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers earnings beat expectations, driven by sales of older drugs - Reuters

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers earnings beat expectations, driven by sales of older drugs By Reuters - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024 - BioSpace

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb stock rises, Merck moves lower. Here's why. - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit - Benzinga

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs - PharmaLive

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers’s stock pops as earnings top estimates and company raises guidance - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Compared to Estimates, Bristol Myers (BMY) Q3 Earnings: A Look at Key Metrics - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers hikes annual earnings guidance as Q3 exceeds expectations; shares up - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Co (BMY) Q3 2024 Earnings: Revenue Surpasses Estimates at $11.9 Billion, GAAP EPS at $0.60 - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb's Earnings Surpass Expectations With Strong Drug Sales - Finimize

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers raises outlook ahead of consensus after Q3 beat - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers: Q3 Earnings Snapshot - The Washington Post

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Earnings Top Q3 Estimates; Pharma Giant Raises Guidance - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb earnings beat by $0.30, revenue topped estimates - Investing.com South Africa

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Raises Guidance on Demand for Eliquis, New Drugs - BNN Bloomberg

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs - CNBC

Oct 31, 2024
pulisher
Oct 31, 2024

Bristol-Myers Squibb Q3 24 Earnings Conference Call At 8:00 AM ET - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

Areas of interest - Bristol Myers Squibb

Oct 31, 2024
pulisher
Oct 30, 2024

Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Drugmakers urge appeals court to revive challenge to US drug price negotiation program - Reuters

Oct 30, 2024
pulisher
Oct 30, 2024

Bristol Myers Squibb Q3 2024 Earnings Preview: Profit decline anticipated - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Is Eli Lilly Stock a Buy? - The Motley Fool

Oct 30, 2024
pulisher
Oct 30, 2024

Jim Cramer Says Bristol-Myers Squibb Company (BMY) Is ‘Too Low’ - Yahoo Finance

Oct 30, 2024
pulisher
Oct 29, 2024

Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day - MarketWatch

Oct 29, 2024
pulisher
Oct 28, 2024

Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN

Oct 28, 2024
pulisher
Oct 28, 2024

Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? - Yahoo Finance

Oct 28, 2024
pulisher
Oct 28, 2024

UTSA announces partnership with Bristol Myers Squibb to advance pharmaceutical discoveries and development - The University of Texas at San Antonio

Oct 28, 2024
pulisher
Oct 28, 2024

Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren (NYSE:BMY) - Seeking Alpha

Oct 28, 2024
pulisher
Oct 28, 2024

Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024 - StockTitan

Oct 28, 2024
pulisher
Oct 28, 2024

Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested three years ago - Simply Wall St

Oct 28, 2024
pulisher
Oct 28, 2024

Psoriasis around the world - Bristol Myers Squibb

Oct 28, 2024
pulisher
Oct 26, 2024

Allspring Global Investments Holdings LLC Has $11.12 Million Stake in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch

Oct 25, 2024
pulisher
Oct 25, 2024

Second Circuit Weighs Whether Bristol-Myers Delayed Cancer Drug - Bloomberg Law

Oct 25, 2024
pulisher
Oct 25, 2024

Citigroup downgrades Bristol-Myers Squibb to 'neutral' - XM

Oct 25, 2024
pulisher
Oct 25, 2024

Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.

Oct 25, 2024
pulisher
Oct 25, 2024

People and business resource groups - Bristol Myers Squibb

Oct 25, 2024
pulisher
Oct 24, 2024

Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance

Oct 24, 2024

Finanzdaten der Bristol Myers Squibb Co-Aktie (BMY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$89.51
price up icon 0.78%
drug_manufacturers_general SNY
$53.27
price up icon 0.74%
drug_manufacturers_general PFE
$28.09
price down icon 0.74%
$319.22
price down icon 0.29%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
Kapitalisierung:     |  Volumen (24h):